These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8954825)

  • 61. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of responses to bradykinin in the rat hindquarters vascular bed.
    Nossaman BD; Kaye AD; Feng CJ; Kang B; Kadowitz PJ
    Am J Physiol; 1997 Feb; 272(2 Pt 2):R631-9. PubMed ID: 9124488
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological Activities and Hydrolysis by Peptidases of [Phospho-Ser(6)]-Bradykinin (pS(6)-BK).
    Assis DM; Juliano L; Paschoalin T; Kouyoumdjian M; Calixto JB; Santos RA; Pertinhez TA; Gauthier F; Moreau T; Blaber M; Juliano MA
    Biochem Pharmacol; 2015 Sep; 97(2):203-14. PubMed ID: 26235942
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril.
    Okuda M; Arakawa K
    J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lack of specific binding of bradykinin and D-Arg [Hyp3, Thi5, D-Tic, Oic8] bradykinin in membranes from rat heart.
    Albus U; Gao X; Greenbaum LM
    Agents Actions Suppl; 1992; 38 ( Pt 3)():73-9. PubMed ID: 1334361
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
    Carmona AK; Juliano L
    Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Substrate specificity of aminopeptidase Ey from hen's (Gallus domesticus) egg yolk.
    Tanaka T; Ichishima E
    Comp Biochem Physiol B; 1993 May; 105(1):105-10. PubMed ID: 7684960
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).
    Inokuchi J; Nagamatsu A
    Biochim Biophys Acta; 1981 Dec; 662(2):300-7. PubMed ID: 6274413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolism of bradykinin by peptidases in the lung.
    Dragović T; Igić R; Erdös EG; Rabito SF
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1491-6. PubMed ID: 8389109
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Aminopeptidase P from bovine lung: solubilization, properties, and potential role in bradykinin degradation.
    Orawski AT; Susz JP; Simmons WH
    Mol Cell Biochem; 1987 Jun; 75(2):123-32. PubMed ID: 3627107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human lung membrane-bound neutral metallo-endopeptidase-catalyzed hydrolysis of bradykinin.
    Zolfaghari R; Little D; Baker CR; Canizaro PC; Behal FJ
    Enzyme; 1989; 42(3):160-73. PubMed ID: 2612455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bradykinin degradation and relation to myocyte contractility.
    Krombach RS; McElmuray JH; Gay DM; Clair MJ; Mukherjee R; Goldberg AT; Baicu SC; Spinale FG
    J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):291-9. PubMed ID: 11150399
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of angiotensin-converting enzyme inhibition and bradykinin peptides in rats with myocardial infarction.
    Qu Z; Xu H; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3410-7. PubMed ID: 26045879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.
    Fernandes L; Fortes ZB; Casarini DE; Nigro D; Tostes RC; Santos RA; de Carvalho MH
    Regul Pept; 2005 Apr; 127(1-3):183-9. PubMed ID: 15680485
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of kininogenase activity of an acidic proteinase isolated from human kidney.
    Gomes RA; Juliano L; Chagas JR; Hial V
    Can J Physiol Pharmacol; 1997 Jun; 75(6):757-61. PubMed ID: 9276160
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bradykinin receptor subtypes in rat lung: effect of interleukin-1 beta.
    Tsukagoshi H; Haddad EB; Barnes PJ; Chung KF
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1257-63. PubMed ID: 7791098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ortho-aminobenzoic acid-labeled bradykinins in interaction with lipid vesicles: fluorescence study.
    Turchiello RF; Lamy-Freund MT; Hirata IY; Juliano L; Ito AS
    Biopolymers; 2002 Dec; 65(5):336-46. PubMed ID: 12389213
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kinin cleavage by human erythrocytes.
    Sidorowicz W; Canizaro PC; Bĕhal FJ
    Am J Hematol; 1984; 17(4):383-91. PubMed ID: 6437213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.